Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-18

Clinical Trial Update: Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration [Phase 4]

View source ↗

Summary

A Phase 4 trial reports that adding lidocaine to levobupivacaine reduces the duration of intrathecal anesthesia in patients with benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chirocaine (levobupivacaine)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: Diskapi Teaching and Research Hospital | Conditions: Benign Prostate Hyperplasia | Phase 4 | Status: COMPLETED